Stryker (SYK) Receives a Buy from BTIG
BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker today and set a price target of $397.00.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zimmerman covers the Healthcare sector, focusing on stocks such as Stryker, Alcon, and GE Healthcare Technologies Inc. According to TipRanks, Zimmerman has an average return of -0.4% and a 40.00% success rate on recommended stocks.
In addition to BTIG, Stryker also received a Buy from Leerink Partners’s Mike Kratky in a report issued today. However, on April 9, Goldman Sachs assigned a Hold rating to Stryker (NYSE: SYK).
Based on Stryker’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $7.17 billion and a net profit of $849 million. In comparison, last year the company earned a revenue of $6.44 billion and had a net profit of $546 million
Based on the recent corporate insider activity of 53 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of SYK in relation to earlier this year. Most recently, in February 2026, Ronda Stryker, a Director at SYK sold 500,000.00 shares for a total of $181,717,233.87.
Read More on SYK:
